Update on the HTA Coordination Group subgroup meetings held on April 25 and 26

By HEOR Staff Writer

April 28, 2023

Update on the HTA Coordination Group subgroup meetings held on April 25 and 26.

Their collective efforts will surely shape the HTA landscape in the long run.

Reference url

Recent Posts

Biomarin Withdraws Voxzogo Reimbursement Application in the Netherlands

By HEOR Staff Writer

March 16, 2026

Voxzogo reimbursement Netherlands hangs in limbo after Biomarin's decision on March 12, 2026, to withdraw its application, leaving children with achondroplasia without access despite parental pleas.
Catalyzing Cardiovascular Health Innovation through Urban Interventions and Collaborative Research

By HEOR Staff Writer

March 12, 2026

Cardiovascular health innovation is at the forefront of the Innovative Health Initiative (IHI), the world's largest public-private partnership in life sciences, which succeeds the Innovative Medicines Initiative (IMI). Key projects from IHI Call 8, such as Cities@Heart, target cardiovascular dise...
EMA Approval Submission for Teclistamab Multiple Myeloma Monotherapy
Johnson & Johnson has submitted a Type II variation application to the European Medicines Agenc...